An Update on Drug-induced Liver Injury

Journal of Clinical and Experimental Hepatology
Harshad Devarbhavi

Abstract

Idiosyncratic drug-induced liver injury (DILI) is an important cause of morbidity and mortality following drugs taken in therapeutic doses. Hepatotoxicity is a leading cause of attrition in drug development, or withdrawal or restricted use after marketing. No age is exempt although adults and the elderly are at increased risk. DILI spans the entire spectrum ranging from asymptomatic elevation in transaminases to severe disease such as acute hepatitis leading to acute liver failure. The liver specific Roussel Uclaf Causality Assessment Method is the most validated and extensively used for determining the likelihood that an implicated drug caused DILI. Asymptomatic elevation in liver tests must be differentiated from adaptation. Drugs producing DILI have a signature pattern although no single pattern is characteristic. Antimicrobial and central nervous system agents including antiepileptic drugs are the leading causes of DILI worldwide. In the absence of a diagnostic test or a biomarker, the diagnosis rests on the evidence of absence of competing causes such as acute viral hepatitis, autoimmune hepatitis and others. Recent studies show that antituberculosis drugs given for active or latent disease are still a major cause of drug-...Continue Reading

Citations

Aug 24, 2019·Nature Reviews. Disease Primers·Raul J AndradeGuruprasad P Aithal
Mar 15, 2019·American Journal of Therapeutics·Anish Vinit PatelTai-Ping Lee
Oct 31, 2019·Yeungnam University Journal of Medicine·Jeong Ill Suh
May 4, 2017·International Journal of Clinical Pharmacy·Tácita Pires de FigueiredoAdriano Max Moreira Reis
Jun 24, 2017·Phytotherapy Research : PTR·Zhi-Jian LiLu-Yong Zhang
Mar 29, 2018·Journal of Complementary & Integrative Medicine·Khalid GhazanfarSeema Akbar
Apr 14, 2017·Hepatology International·Yue-Cheng YuUNKNOWN Chinese Medical Association (CMA)
Apr 25, 2017·Critical Reviews in Toxicology·Ana Margarida AraújoPaula Guedes de Pinho
Feb 7, 2018·Hepatology Communications·Yo-Ichi YamashitaHideo Baba
Nov 9, 2018·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Jinho LeeIn-Hyuk Ha
Jan 11, 2020·Frontiers in Pharmacology·Lucy Meunier, Dominique Larrey
Dec 14, 2016·Asian Pacific Journal of Tropical Medicine·María Adelina Jiménez-ArellanesRosalba León-Díaz
Mar 22, 2020·Nanomaterials·Elisabeth EljeElise Rundén-Pran
Apr 20, 2019·SAGE Open Medical Case Reports·Miyako KishimotoKazushige Washizaki
Jul 9, 2020·SAGE Open Medical Case Reports·Ginny VargheseRafaat Saad
Dec 29, 2020·Expert Opinion on Drug Safety·Haochen JiangPeihua Luo
Mar 19, 2021·Frontiers in Cell and Developmental Biology·Ana S SerrasJoana P Miranda
Mar 23, 2021·Journal of Clinical and Experimental Hepatology·Nanjegowda Sunil KumarKandiyil Sunil Kumar
Apr 16, 2021·Frontiers in Medicine·Shuai-Shuai ChenJia-Bo Wang
Mar 19, 2021·Journal of Clinical Psychopharmacology·Gregory NikogosyanMichele Wang
Jun 1, 2021·Curēus·Mahesh BotejueRasiq Zackria
May 8, 2021·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Terry Cheuk-Fung YipGrace Lai-Hung Wong
Jul 19, 2021·Archives of Toxicology·Guillermo QuintásJosé V Castell
Apr 14, 2020·Current Therapeutic Research, Clinical and Experimental·Kannan SridharanHusain A M Al Ajooz
Nov 26, 2021·Naunyn-Schmiedeberg's Archives of Pharmacology·Lamiaa A KhatabAsser I Ghoneim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
Harshad Devarbhavi
Current Opinion in Pediatrics
Mansi D AminDaniel H Leung
© 2022 Meta ULC. All rights reserved